Rethinking Clinical Trials For The Future

The global pandemic altered the course of clinical trials, accelerating industry efforts to change how trials are conducted. The shift to decentralized trials, remote visits, virtual experiences, and faster regulatory reviews requires the industry to embrace new ways of operating, and take a fresh approach to how technology is deployed, how stakeholders collaborate, how administrative tasks can be simplified and automated - ultimately, drive greater efficiency in clinical trials and accelerate the industry's move toward patient-centric healthcare.